AzTrials
AzTrials

TraumaNCT01509092

Comparative Study Between Early Vitrectomy and Observation for Spontaneous Closure of Traumatic Macular Hole

A study testing vitrectomy surgery in people with Trauma and Macular Hole, run by Peking University Third Hospital at 8 sites in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to compare the anatomical and visual recovery of eyes with traumatic macular hole (TMH) following either early vitrectomy or 6-month observation. Read more about this study

Who is it for?
Any age
Conditions the study is for
Trauma, Macular Hole
What is being tested?
vitrectomy surgery
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
44 participants
Where
8 sitesChina
Study dates
Jan 2012to Jun 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • closed globe injury
  • identification of full-thickness macular hole by optical coherence tomography within one month after trauma

Who cannot join

  • open globe injury
  • coexistence of idiopathic macular hole
  • severe opaque in the visual axis caused by the injury(eg. severe cataract, severe vitreous hemorrhage)
  • combined injuries requiring immediate surgical intervention (eg. lens dislocation, retinal detachment, cyclodialysis)
  • coexistence of high myopia
  • coexistence of choroidal rupture or subretinal hemorrhage within the diameter of 400μm from the center of the foveola
  • coexistence of severe optic nerve injury (no light perception, positive afferent pupillary defect)

Trial locations and contacts

8 sites in 1 country.

8 sites in 1 country

China8 sites
  • China - Japan Friendship Hospital

    Beijing

  • Peking University Third Hospital

    Beijing

  • Southwest Eye hospital of Third Military Medical University

    Chongqing

  • The Second Affiliated Hospital Zhejiang University School of Medicine

    Hangzhou, Zhejiang

  • Shanghai Ninth People's Hospital Affiliated Shanghai JiaoTong University school of Medicine

    Shanghai

  • Weifang Eye Hospital

    Weifang, Shandong

  • Wenzhou Medical College

    Wenzhou, Zhejiang

  • Eye Hospital of Hebei Province

    Xingtai, Hebei

Other trials in China

About this study

Official title: Traumatic Macular Hole: Six-months Observation Versus Early Surgical Intervention, A Multicenter Clinical Trial

The purpose of this study is to compare the anatomical and visual recovery of eyes with traumatic macular hole (TMH) following either early vitrectomy or 6-month observation.

Read the detailed description

Patients who received vitrectomy immediately after the injury were compared with patients who were observed for six months for spontaneously closure.The closure rate, foveal microstructure, and final visual acuity were analyzed.

Conditions
Trauma, Macular Hole
Being tested
vitrectomy surgery
Keywords
traumatic macular hole, vitrectomy, observation
Medical subject headings
Wounds and Injuries, Retinal Perforations

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • vitrectomy surgeryProcedure or surgery

    "pars plana vitrectomy +internal limiting membrane peeling" done immediately after the identification of the macular hole

Study groups in NCT01509092
Study groupRoleWhat they receive
obervationNo interventionpatients in this arm received 6-months observation alone after injury
Surgical interventionActive comparatorpatients in this arm received vitrectomy surgery as soon as possible after injury
Receives: Procedure: vitrectomy surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. macular hole closure rate

    Measured: 6 month after injury

Secondary outcomes (3)
  1. central foveal thickness

    Measured: 6 month after hole closure

  2. length of inner-segment outer-segment junction defect

    Measured: 6 month after hole closure

  3. final visual acuity

    Measured: 6 month after hole closure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jan 2012 (estimated)
  2. Study startJan 2012
  3. Primary completionFeb 2014
  4. Study completionJun 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
44 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01509092
Sponsor's protocol ID
PekingUTH-TMH-2011
Status last verified
Jan 2012
First submitted
28 Dec 2011
Last updated
7 Oct 2014
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing vitrectomy surgery in people with Trauma and Macular Hole, run by Peking University Third Hospital at 8 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Oct 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 8 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

macular hole closure rate (time frame: 6 month after injury). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2014.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in